Ionis Pharmaceuticals (IONS) Retained Earnings (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Retained Earnings of -$2.8 billion for Q2 2026, down 24.86% year-over-year from -$3.8 billion in Q2 2025, and down 4.21% quarter-over-quarter from -$2.7 billion in Q1 2026.
Ionis Pharmaceuticals (IONS) Retained Earnings (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Retained Earnings history runs 18 years deep, the most recent figure standing at -$2.8 billion for Q2 2026.
- In Q2 2026, Retained Earnings fell 24.86% year-over-year to -$2.8 billion; the TTM figure through Jun 2026 stood at -$2.8 billion (down 24.86% YoY), while the FY2025 annual figure was -$2.6 billion, down 16.95% from the prior year.
- Retained Earnings for Q2 2026 stood at -$2.8 billion, down from -$2.7 billion in the prior quarter.
- The five-year high for Retained Earnings was -$1.2 billion in Q1 2022, with the low at -$2.8 billion in Q2 2026.
- The 5-year median for Retained Earnings is -$2.0 billion (2024), against an average of -$2.0 billion.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings climbed 0.53% in 2022, then declined 29.73% in 2023.
- Ionis Pharmaceuticals' Retained Earnings stood at -$1.4 billion in 2022, then decreased by 25.62% to -$1.8 billion in 2023, then dropped by 25.27% to -$2.2 billion in 2024, then dropped by 16.95% to -$2.6 billion in 2025, then retreated by 7.87% to -$2.8 billion in 2026.
- Business Quant data shows IONS's Retained Earnings at -$2.8 billion in Q2 2026, -$2.7 billion in Q1 2026, and -$2.6 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | -2.84 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.84 Bn |
| Mar 31, 2026 | -2.72 Bn |
| Dec 31, 2025 | -2.63 Bn |
| Sep 30, 2025 | -2.40 Bn |
| Jun 30, 2025 | -2.27 Bn |
| Mar 31, 2025 | -2.40 Bn |
| Dec 31, 2024 | -2.25 Bn |
| Sep 30, 2024 | -2.15 Bn |
| Jun 30, 2024 | -2.00 Bn |
| Mar 31, 2024 | -1.94 Bn |
| Dec 31, 2023 | -1.80 Bn |
| Sep 30, 2023 | -1.79 Bn |
| Jun 30, 2023 | -1.64 Bn |
| Mar 31, 2023 | -1.55 Bn |
| Dec 31, 2022 | -1.43 Bn |
| Sep 30, 2022 | -1.38 Bn |
| Jun 30, 2022 | -1.33 Bn |
| Mar 31, 2022 | -1.23 Bn |
| Dec 31, 2021 | -1.16 Bn |
| Sep 30, 2021 | -1.38 Bn |